Alyeska Investment Group, L.P. Guardant Health, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $20.5 Million - $54.9 Million	-709,779 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $22.3 Million - $46.5 Million	463,212 Added 187.86%	709,779 $47 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $19.4 Million - $26.4 Million	219,168 Added 799.91%	246,567 $24.7 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $1.61 Million - $2.29 Million	-25,111 Reduced 47.82%	27,399 $0
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $1.8 Million - $5.14 Million	52,510 New	52,510 $0

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.62B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.